ESPR
NASDAQ · Pharmaceuticals
Esperion Therapeutics Inc
$3.18
-0.01 (-0.31%)
Open$3.18
Previous Close$3.19
Day High$3.19
Day Low$3.18
52W High$4.18
52W Low$1.80
Volume—
Avg Volume21.88M
Market Cap819.46M
P/E Ratio—
EPS$-0.06
SectorPharmaceuticals
Analyst Ratings
Sell
11 analysts
Price Target
+494.7% upside
Current
$3.18
$3.18
Target
$18.91
$18.91
$12.50
$18.91 avg
$21.23
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 499.77M | 285.94M | 122.60M |
| Net Income | -28,114,344 | -14,477,005 | 36.77M |
| Profit Margin | -5.6% | -5.4% | 30.0% |
| EBITDA | 74.86M | 40.69M | 61.92M |
| Free Cash Flow | — | — | 30.39M |
| Rev Growth | +74.8% | +74.8% | -8.9% |
| Debt/Equity | — | — | 0.54 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,170.14 | +0.45% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.19 | -0.10% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $150.91 | +0.94% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.93 | +0.68% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.25 | -0.59% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $72.86 | +2.15% | 11.5 | 30.15B |